INFLUENCE OF GARLIC POWDER ON CUTANEOUS MICROCIRCULATION - A RANDOMIZED PLACEBO-CONTROLLED DOUBLE-BLIND CROSS-OVER STUDY IN APPARENTLY HEALTHY-SUBJECTS

被引:0
|
作者
JUNG, EM [1 ]
JUNG, F [1 ]
MROWIETZ, C [1 ]
KIESEWETTER, H [1 ]
PINDUR, G [1 ]
WENZEL, E [1 ]
机构
[1] UNIV SAARLAND,DEPT CLIN HAEMOSTASIOL & TRANSFUS MED,W-6650 HOMBURG,GERMANY
来源
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 1991年 / 41-1卷 / 06期
关键词
BLOOD FLOW STIMULANTS; CUTANEOUS MICROCIRCULATION; GARLIC POWDER; CLINICAL STUDIES; RHEOREGULATION; KWAI; SAPEC;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In a randomized placebo-controlled double-blind cross-over study it could be shown that 5 h after the administration of garlic powder (Kwai(R), Sapec(R); total dose of 900 mg garlic powder) a significant increase in capillary skin perfusion by 55 % occurs in the healthy volunteers. Placebo did not cause any changes. The difference between the two study phases is also significant. The increased erythrocyte velocity results from vasodilation of precapillary arterioles which increases diameter of erythrocyte column by an average of 8.6 %. Simultaneously inflow of interstitial fluidity accompanied by a significant decrease in haematocrit and plasma viscosity occurs (rheoregulation).
引用
收藏
页码:626 / 630
页数:5
相关论文
共 50 条
  • [41] Small Amounts of Gluten in Subjects With Suspected Nonceliac Gluten Sensitivity: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial
    Di Sabatino, Antonio
    Volta, Umberto
    Salvatore, Chiara
    Biancheri, Paolo
    Caio, Giacomo
    De Giorgio, Roberto
    Di Stefano, Michele
    Corazza, Gino R.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (09) : 1604 - +
  • [42] Lactobacillus reuteri supplements do not affect salivary IgA or cytokine levels in healthy subjects: A randomized, double-blind, placebo-controlled, cross-over trial
    Jorgensen, Mette Rose
    Keller, Mette Kirstine
    Kragelund, Camilla
    Hamberg, Kristina
    Ericson, Dan
    Nielsen, Claus Henrik
    Twetman, Svante
    ACTA ODONTOLOGICA SCANDINAVICA, 2016, 74 (05) : 399 - 404
  • [43] Effects of lithium on saccadic eye movements in healthy subjects in a ten-day double-blind placebo-controlled cross-over pilot study
    Amado, I
    Galinowski, A
    Daban, C
    Ramdane-Cherif, Z
    Poirier, E
    Bourdel, MC
    Poirier, MF
    Krebs, MO
    PHARMACOPSYCHIATRY, 2005, 38 (06) : 321 - 325
  • [44] A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease
    Lopez-Sendon Moreno, Jose Luis
    Garcia Caldentey, Juan
    Trigo Cubillo, Patricia
    Ruiz Romero, Carolina
    Garcia Ribas, Guillermo
    Alonso Arias, M. A. Alonso
    Jesus Garcia de Yebenes, Maria
    Maria Tolon, Rosa
    Galve-Roperh, Ismael
    Sagredo, Onintza
    Valdeolivas, Sara
    Resel, Eva
    Ortega-Gutierrez, Silvia
    Laura Garcia-Bermejo, Maria
    Fernandez Ruiz, Javier
    Guzman, Manuel
    de Yebenes Prous, Justo Garcia
    JOURNAL OF NEUROLOGY, 2016, 263 (07) : 1390 - 1400
  • [45] A randomized double-blind, placebo-controlled, cross-over trial (Vestparoxy) of the treatment of vestibular paroxysmia with oxcarbazepine
    Otmar Bayer
    Tatiana Brémová
    Michael Strupp
    Katharina Hüfner
    Journal of Neurology, 2018, 265 : 291 - 298
  • [46] Hyoscine for clozapine-induced hypersalivation: a double-blind, randomized, placebo-controlled cross-over trial
    Segev, Aviv
    Evans, Anthony
    Hodsoll, John
    Whiskey, Eromona
    Sheriff, Rebecca S.
    Shergill, Sukhi
    MacCabe, James H.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2019, 34 (02) : 101 - 107
  • [47] Anti-Inflammatory and Antioxidant Effects of Resveratrol in Healthy Smokers A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial
    Bo, S.
    Ciccone, G.
    Castiglione, A.
    Gambino, R.
    De Michieli, F.
    Villois, P.
    Durazzo, M.
    Cavallo-Perin, P.
    Cassader, M.
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (10) : 1323 - 1331
  • [48] A randomized double-blind, placebo-controlled, cross-over trial (Vestparoxy) of the treatment of vestibular paroxysmia with oxcarbazepine
    Bayer, Otmar
    Bremova, Tatiana
    Strupp, Michael
    Huefner, Katharina
    JOURNAL OF NEUROLOGY, 2018, 265 (02) : 291 - 298
  • [49] Modulation of hippocampal activity in schizophrenia with levetiracetam: a randomized, double-blind, cross-over, placebo-controlled trial
    Maxwell J. Roeske
    Maureen McHugo
    Baxter Rogers
    Kristan Armstrong
    Suzanne Avery
    Manus Donahue
    Stephan Heckers
    Neuropsychopharmacology, 2024, 49 : 681 - 689
  • [50] A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington’s disease
    Jose Luis López-Sendón Moreno
    Juan García Caldentey
    Patricia Trigo Cubillo
    Carolina Ruiz Romero
    Guillermo García Ribas
    M. A. Alonso Alonso Arias
    María Jesús García de Yébenes
    Rosa María Tolón
    Ismael Galve-Roperh
    Onintza Sagredo
    Sara Valdeolivas
    Eva Resel
    Silvia Ortega-Gutierrez
    María Laura García-Bermejo
    Javier Fernández Ruiz
    Manuel Guzmán
    Justo García de Yébenes Prous
    Journal of Neurology, 2016, 263 : 1390 - 1400